Dana-Farber Cancer Institute /ID# 152735

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Myelodysplastic Syndromes (MDS)

Studies at this site

• A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS) — Running, not enrolling